{ "model": { "rank": 16362, "code": "thing-q366868", "model_id": "vr.tr.congenital-adrenal-hyperplasia", "name": "congenital adrenal hyperplasia", "purpose": "Let an agent explain congenital adrenal hyperplasia in general terms, relay types, genetics, screening, emergency adrenal crisis routing and treatment approaches from endocrinology sources, present debates about genital surgery with positions attributed and respectfully, describe the named forms and flag the loosely filed alias, and distinguish CAH from Addison disease, adrenal tumours, androgen insensitivity and polycystic ovary syndrome, without individual medical advice.", "family": "Thing Registry", "category": "Cross-cutting context", "status": "research-draft", "kind": "thing", "plane": "XCT", "domain": "XCT.STA", "industry": "", "version": "", "url": "/models/thing/q366868/", "tier": 2, "score": 32, "payload": { "layer": "wikidata", "aliases": [ "cytochrome b5 deficiency", "salt-wasting 21-hydroxylase deficiency", "classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, simple virilizing form", "congenital adrenal hyperplasia due to 11β-hydroxylase deficiency", "congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency", "congenital adrenal hyperplasia due to 21-hydroxylase deficiency", "congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency", "lipoid congenital adrenal hyperplasia", "non-classic congenital adrenal hyperplasia", "isolated 17,20-lyase deficiency" ], "aliasCount": 10, "merged": 10, "knownIn": 32, "facets": null, "markers": [], "lexicalClass": "", "senseRank": null, "alsoRegisteredAs": null, "source": { "dataset": "wikidata", "item": "Q366868", "url": "https://www.wikidata.org/wiki/Q366868", "license": "CC0 1.0" } }, "research": { "vercy": "1.0-draft", "publication": { "status": "research-draft", "adjudicationStatus": "unreviewed", "publishableCanonical": false, "generatedAt": "2026-09-14T01:02:47Z", "providers": [ "Claude" ], "breadth": "written by Claude from model knowledge without web access - no source was read, every claim is a lead to verify", "pass": 2, "wave": 4, "engine": "claude" }, "metaModel": { "id": "THING-Q366868", "registryId": "vr.tr.congenital-adrenal-hyperplasia", "name": "congenital adrenal hyperplasia", "version": "0.2.0-wave.4", "entryKind": "thing", "family": "Thing Registry", "domain": [ "XCT.STA" ], "status": "research-draft" }, "canonicalUrl": "https://ver.cy/models/thing/q366868/", "model": { "registry_id": "vr.tr.congenital-adrenal-hyperplasia", "name": "congenital adrenal hyperplasia", "purpose": "Let an agent explain congenital adrenal hyperplasia in general terms, relay types, genetics, screening, emergency adrenal crisis routing and treatment approaches from endocrinology sources, present debates about genital surgery with positions attributed and respectfully, describe the named forms and flag the loosely filed alias, and distinguish CAH from Addison disease, adrenal tumours, androgen insensitivity and polycystic ovary syndrome, without individual medical advice.", "definition": "A group of inherited disorders in which an enzyme needed to make cortisol in the adrenal glands is deficient, causing adrenal enlargement and altered hormone levels, most often 21-hydroxylase deficiency, which accounts for most cases and occurs in classic salt-wasting and simple virilising forms and a milder non-classic form, with rarer forms the registry aliases name such as 11-beta-hydroxylase and 17-alpha-hydroxylase deficiencies; cytochrome b5 deficiency, also listed, is a separate rare condition affecting androgen synthesis or red blood cells and appears loosely filed. Many countries screen newborns because salt-wasting crises can be life-threatening, and lifelong hormone treatment is common. Care for people with atypical genital development is debated, including the timing of surgery, and positions of medical bodies and intersex advocates are attributed.", "what_it_is_for": "Not applicable; a group of genetic disorders.", "affordances": [ "explain types and genetics", "relay screening and emergency signs", "describe named forms", "present care debates with attribution" ], "distinguishing_features": [ "Enzyme deficiency", "Cortisol and aldosterone effects", "Newborn screening", "Lifelong treatment" ], "appearance": "Varies; may include atypical genitalia at birth, early puberty or no visible signs.", "visual_identification": [ "Inherited cortisol synthesis enzyme deficiency", "Cytochrome b5 deficiency, salt-wasting 21-hydroxylase deficiency, simple virilising 21-hydroxylase deficiency, 11-beta-hydroxylase deficiency, 17-alpha-hydroxylase deficiency, 21-hydroxylase deficiency", "Addison disease is acquired adrenal failure; adrenal tumours are growths; androgen insensitivity affects receptors; PCOS is a common endocrine condition" ], "physical_properties": [ { "quantity": "21-hydroxylase deficiency share", "typical_range": "about 90-95 percent of cases", "unit": "note", "note": "attributed" }, { "quantity": "classic CAH incidence", "typical_range": "roughly 1 in 10,000-20,000 births", "unit": "note", "note": "varies by population" }, { "quantity": "inheritance", "typical_range": "autosomal recessive", "unit": "note", "note": "" } ], "families_and_kinds": [ "classic salt-wasting CAH", "classic simple virilising CAH", "non-classic CAH", "rare enzyme deficiencies" ], "related_models": [ { "relation": "is a kind of", "target": "adrenal hyperplasia", "why": "in registry terms" }, { "relation": "is detected by", "target": "newborn screening", "why": "" }, { "relation": "can cause", "target": "adrenal crisis", "why": "" }, { "relation": "is contrasted with", "target": "Addison s disease", "why": "" } ], "identifiers": [], "standards_and_regulation": [ "Endocrine Society CAH clinical practice guideline", "Newborn screening programmes", "Emergency steroid card guidance" ], "failure_modes_and_hazards": [ "Missed adrenal crisis", "Stigmatising language about sex development", "Partisan framing of surgery debates" ], "in_scope": [], "out_of_scope": [], "characteristics": [] }, "sources": [], "structure": { "bundles": [ { "id": "understand", "name": "Understand", "description": "What CAH is.", "rationale": "Science.", "layers": [ { "id": "definition", "name": "Definition", "description": "Definition.", "findings": [ { "id": "definition-finding", "name": "Definition", "description": "Definition.", "questions": [ { "text": "Is a baby or person with CAH vomiting, very drowsy, floppy or collapsing, in which case give emergency steroid as instructed and call emergency services?", "kind": "boundary" }, { "text": "What is congenital adrenal hyperplasia, and how does it differ from Addison disease, adrenal tumours, androgen insensitivity and PCOS?", "kind": "definition" } ] } ] }, { "id": "forms", "name": "Forms", "description": "Named forms.", "findings": [ { "id": "forms-finding", "name": "Forms", "description": "Forms.", "questions": [ { "text": "What are salt-wasting, simple virilising, 11-beta and 17-alpha-hydroxylase forms, and why is cytochrome b5 deficiency different?", "kind": "definition" }, { "text": "Which entry fits the specific form?", "kind": "action" } ] } ] } ] }, { "id": "biology", "name": "Biology", "description": "Biology.", "rationale": "Science.", "layers": [ { "id": "enzymes", "name": "Enzymes", "description": "Steroid pathway.", "findings": [ { "id": "enzymes-finding", "name": "Enzymes", "description": "Enzymes.", "questions": [ { "text": "How do enzyme blocks shift steroid production towards androgens?", "kind": "provenance" }, { "text": "Which references are standard?", "kind": "provenance" } ] } ] }, { "id": "genetics", "name": "Genetics", "description": "Genetics.", "findings": [ { "id": "genetics-finding", "name": "Genetics", "description": "Genetics.", "questions": [ { "text": "How is CAH inherited, and what does carrier testing involve?", "kind": "provenance" }, { "text": "Which sources are cited?", "kind": "provenance" } ] } ] } ] }, { "id": "care", "name": "Care", "description": "Screening and treatment.", "rationale": "Regulation.", "layers": [ { "id": "screening", "name": "Screening", "description": "Newborn screening.", "findings": [ { "id": "screening-finding", "name": "Screening", "description": "Screening.", "questions": [ { "text": "How does newborn screening detect CAH, checked against current programmes?", "kind": "provenance" }, { "text": "Is the information current?", "kind": "boundary" } ] } ] }, { "id": "treatment", "name": "Treatment", "description": "Treatment approaches.", "findings": [ { "id": "treatment-finding", "name": "Treatment", "description": "Treatment.", "questions": [ { "text": "What general treatment approaches and sick-day rules do guidelines describe?", "kind": "provenance" }, { "text": "Which entry fits adrenal crisis?", "kind": "action" } ] } ] } ] }, { "id": "context", "name": "Context", "description": "Debates.", "rationale": "Attribution.", "layers": [ { "id": "surgery", "name": "Surgery", "description": "Genital surgery debate.", "findings": [ { "id": "surgery-finding", "name": "Surgery", "description": "Surgery.", "questions": [ { "text": "What do medical societies, human rights bodies and intersex advocates say about the timing of genital surgery, with positions attributed?", "kind": "provenance" }, { "text": "Is the presentation neutral, respectful and attributed?", "kind": "boundary" } ] } ] }, { "id": "prenatal", "name": "Prenatal", "description": "Prenatal treatment debate.", "findings": [ { "id": "prenatal-finding", "name": "Prenatal", "description": "Prenatal.", "questions": [ { "text": "What concerns have been raised about prenatal dexamethasone, as guidelines report?", "kind": "provenance" }, { "text": "Is the presentation neutral and attributed?", "kind": "boundary" } ] } ] } ] } ] }, "openQuestions": [ "The registry alias cytochrome b5 deficiency should be moved to its own entry", "Should non-classic CAH be a separate entry?", "How should guidelines and advocacy positions be linked?" ], "statistics": { "bundles": 4, "layers": 8, "findings": 8, "questions": 16 } }, "draft": { "generator": "vr.draft.v3", "status": "draft-generated", "researched": false, "archetype": "abstract concept", "method": "Written from the archetype playbook - what this kind of thing needs beyond identity and provenance - and from the structure that recurred across 6,333 models already researched by two engines. Applied to this entry by rule. No source was read for this thing and no claim here is researched. This entry carries no facets of its own, so they were inferred from its domain - a guess about a whole domain applied to one thing.", "facetsInferred": true, "nextPass": "A researcher replaces this draft with a sourced specification. Treat every sentence below as a proposal to argue with.", "purpose": "Give an agent a durable, checkable way to recognise a congenital adrenal hyperplasia, record what state it is in, and decide what may be done with it.", "whatItIs": "Let an agent explain congenital adrenal hyperplasia in general terms, relay types, genetics, screening, emergency adrenal crisis routing and treatment approaches from endocrinology sources, present debates about genital surgery with positions attributed and respectfully, describe the named forms and flag the loosely filed alias, and distinguish CAH from Addison disease, adrenal tumours, androgen insensitivity and polycystic ovary syndrome, without individual medical advice.", "characteristics": { "substance": "abstract", "origin": "conceptual", "agency": "inert" }, "whatYouCanDoWithIt": [ "observed and measured" ], "distinguishingFeatures": [ "Names folded into this entry, which a task may need to split apart again: cytochrome b5 deficiency, salt-wasting 21-hydroxylase deficiency, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, simple virilizing form, congenital adrenal hyperplasia due to 11β-hydroxylase deficiency, congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency, congenital adrenal hyperplasia due to 21-hydroxylase deficiency, congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency, lipoid congenital adrenal hyperplasia, non-classic congenital adrenal hyperplasia, isolated 17,20-lyase deficiency.", "10 finer distinctions are held as aliases rather than separate entries, because telling them apart needs a task that asks for it.", "Described in 32 Wikipedia languages, which is a measure of how widely the thing is known, not of how important it is." ], "openQuestionsForResearch": [ "Which of the bundles below does a real task actually need, and which are ceremony?", "What does this thing have that the facets do not capture at all?", "Which neighbouring kind is most often confused with a congenital adrenal hyperplasia, and on what evidence are they told apart?" ], "whatItIsMadeOf": "an abstraction with no physical instance", "physicalCharacter": [ "Does nothing on its own; everything it does, something else did to it.", "These come from the domain this entry sits in rather than from the entry itself, so treat them as a first guess about the whole domain applied to one thing." ], "whatCanBeDoneWithIt": [ "observe it, measure it, record its state" ], "howItIsRecognised": [ "Nothing to see. What is recognised is an instance of it, and which instances count is exactly what is argued about." ], "relatedModels": [ { "relation": "covers", "note": "Finer kinds folded into this entry because telling them apart needs a task that asks for it. Each is a model waiting to be split out when one does.", "targets": [ "cytochrome b5 deficiency", "salt-wasting 21-hydroxylase deficiency", "classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, simple virilizing form", "congenital adrenal hyperplasia due to 11β-hydroxylase deficiency", "congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency", "congenital adrenal hyperplasia due to 21-hydroxylase deficiency", "congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency", "lipoid congenital adrenal hyperplasia", "non-classic congenital adrenal hyperplasia", "isolated 17,20-lyase deficiency" ] } ], "standing": "Described in 32 Wikipedia languages, which measures how widely it is written about rather than how important or how common it is. 10 finer distinctions are held inside this entry as names rather than as separate models.", "structure": { "bundles": [ { "id": "identity-and-classification", "name": "Identity, naming and classification", "description": "How an agent tells one congenital adrenal hyperplasia from another, and a congenital adrenal hyperplasia from things that resemble it.", "rationale": "Recognition comes before every other claim. Without stable identity nothing else in the model can be trusted to be about the same thing twice.", "layers": [ { "id": "naming-and-identifiers", "name": "Names and identifiers", "description": "The names this thing goes by and the identifiers that survive translation and time.", "findings": [ { "id": "preferred-name-and-aliases", "name": "Preferred name, aliases and local names", "description": "Which name to use, which names mean the same thing, and which merely sound similar.", "questions": [ { "id": "preferred-name-and-aliases-q01", "text": "What identifies and describes the name of a congenital adrenal hyperplasia, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "preferred-name-and-aliases-q02", "text": "Who or what asserted this about the name of a congenital adrenal hyperplasia, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "preferred-name-and-aliases-q03", "text": "What may an agent decide or do once the name of a congenital adrenal hyperplasia is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] }, { "id": "stable-identifiers", "name": "Stable identifiers and external keys", "description": "Identifiers that keep pointing at this kind of thing across systems and languages.", "questions": [ { "id": "stable-identifiers-q01", "text": "What identifies and describes an identifier for a congenital adrenal hyperplasia, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "stable-identifiers-q02", "text": "Who or what asserted this about an identifier for a congenital adrenal hyperplasia, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "stable-identifiers-q03", "text": "What may an agent decide or do once an identifier for a congenital adrenal hyperplasia is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "classification-and-granularity", "name": "Classification and granularity", "description": "Where a congenital adrenal hyperplasia sits among kinds, and how finely a task needs to cut it.", "findings": [ { "id": "kind-and-parents", "name": "Kind, parents and neighbouring kinds", "description": "The classes this thing belongs to and the ones it is next to.", "questions": [ { "id": "kind-and-parents-q01", "text": "What identifies and describes the kind of a congenital adrenal hyperplasia, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "kind-and-parents-q02", "text": "Who or what asserted this about the kind of a congenital adrenal hyperplasia, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "kind-and-parents-q03", "text": "What may an agent decide or do once the kind of a congenital adrenal hyperplasia is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] }, { "id": "distinguishing-features", "name": "Distinguishing features", "description": "What separates a congenital adrenal hyperplasia from the things most often confused with it.", "questions": [ { "id": "distinguishing-features-q01", "text": "What identifies and describes what distinguishes a congenital adrenal hyperplasia, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "distinguishing-features-q02", "text": "Who or what asserted this about what distinguishes a congenital adrenal hyperplasia, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "distinguishing-features-q03", "text": "What may an agent decide or do once what distinguishes a congenital adrenal hyperplasia is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] }, { "id": "state-and-lifecycle", "name": "State and lifecycle", "description": "The states a congenital adrenal hyperplasia passes through and the events that move it between them.", "rationale": "Most decisions about a thing depend on what state it is in now, which is a claim with a time on it, not a property.", "layers": [ { "id": "lifecycle-stages", "name": "Lifecycle stages", "description": "From coming into existence to ceasing to be one of these.", "findings": [ { "id": "stages-and-transitions", "name": "Stages and transitions", "description": "The stages worth naming and what moves a congenital adrenal hyperplasia between them.", "questions": [ { "id": "stages-and-transitions-q01", "text": "What identifies and describes the lifecycle of a congenital adrenal hyperplasia, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "stages-and-transitions-q02", "text": "Who or what asserted this about the lifecycle of a congenital adrenal hyperplasia, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "stages-and-transitions-q03", "text": "What may an agent decide or do once the lifecycle of a congenital adrenal hyperplasia is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "observations-and-status", "name": "Observations and current status", "description": "What is observed about a congenital adrenal hyperplasia, how often and by whom.", "findings": [ { "id": "observation-record", "name": "Observation record", "description": "How an observation of a congenital adrenal hyperplasia is recorded so that it can be superseded rather than overwritten.", "questions": [ { "id": "observation-record-q01", "text": "What identifies and describes an observation of a congenital adrenal hyperplasia, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "observation-record-q02", "text": "Who or what asserted this about an observation of a congenital adrenal hyperplasia, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "observation-record-q03", "text": "What may an agent decide or do once an observation of a congenital adrenal hyperplasia is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] }, { "id": "definitions-in-contest", "name": "Definitions and who holds them", "description": "What congenital adrenal hyperplasia is taken to mean, and by whom.", "rationale": "When a field disagrees about a concept, the disagreement is the content. A model that picks one definition silently destroys the information.", "layers": [ { "id": "competing-definitions", "name": "Competing definitions", "description": "The main readings and the traditions behind them.", "findings": [ { "id": "definition-map", "name": "Definitions and their holders", "description": "Each definition with the school or body that holds it.", "questions": [ { "id": "definition-map-q01", "text": "Which definitions of congenital adrenal hyperplasia are in use, and which tradition or body holds each?", "kind": "definition" }, { "id": "definition-map-q02", "text": "What turns on the difference between them in practice?", "kind": "boundary" } ] } ] }, { "id": "operationalisation", "name": "Operationalisation", "description": "How it is measured or applied when it has to be.", "findings": [ { "id": "operational-record", "name": "Measures and proxies", "description": "Instruments and indicators used to stand in for it.", "questions": [ { "id": "operational-record-q01", "text": "How is congenital adrenal hyperplasia operationalised or measured in practice, and by what instrument?", "kind": "measurement" }, { "id": "operational-record-q02", "text": "What does that operationalisation leave out, and when does that matter?", "kind": "boundary" } ] } ] } ] }, { "id": "instances-and-use", "name": "Instances, use and consequence", "description": "What counts as an instance of congenital adrenal hyperplasia and what follows from calling something that.", "rationale": "Applying a concept is an act with consequences, so a model must say what the label licenses and what it does not.", "layers": [ { "id": "instances", "name": "What counts as an instance", "description": "Clear cases, borderline cases and non-cases.", "findings": [ { "id": "instance-tests", "name": "Tests for an instance", "description": "What would settle whether something falls under it.", "questions": [ { "id": "instance-tests-q01", "text": "What would settle whether something is an instance of congenital adrenal hyperplasia?", "kind": "boundary" }, { "id": "instance-tests-q02", "text": "Which borderline cases are argued about, and on what grounds?", "kind": "definition" } ] } ] }, { "id": "consequence", "name": "Consequence of application", "description": "Rights, duties or decisions that follow from the label.", "findings": [ { "id": "consequence-record", "name": "What the label licenses", "description": "What an agent may do once something is classified this way.", "questions": [ { "id": "consequence-record-q01", "text": "What follows practically once something is treated as congenital adrenal hyperplasia?", "kind": "action" }, { "id": "consequence-record-q02", "text": "What must an agent not infer from the label alone?", "kind": "action" } ] } ] } ] }, { "id": "provenance-and-evidence", "name": "Provenance, evidence and time", "description": "Where every claim about a congenital adrenal hyperplasia came from and when it held.", "rationale": "A claim without a source and a time cannot be superseded, only overwritten, and an agent that overwrites loses the ability to explain itself.", "layers": [ { "id": "source-and-authority", "name": "Source and authority", "description": "Who said it, on what evidence, and how strongly.", "findings": [ { "id": "claim-provenance", "name": "Claim provenance and confidence", "description": "The authority behind each claim about a congenital adrenal hyperplasia and how confident it is.", "questions": [ { "id": "claim-provenance-q01", "text": "What identifies and describes a claim about a congenital adrenal hyperplasia, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "claim-provenance-q02", "text": "Who or what asserted this about a claim about a congenital adrenal hyperplasia, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "claim-provenance-q03", "text": "What may an agent decide or do once a claim about a congenital adrenal hyperplasia is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "time-and-versions", "name": "Time, versions and supersession", "description": "When a claim was true, when it was learnt, and what replaced it.", "findings": [ { "id": "validity-and-supersession", "name": "Validity period and supersession", "description": "How an old claim about a congenital adrenal hyperplasia is retired without being erased.", "questions": [ { "id": "validity-and-supersession-q01", "text": "What identifies and describes the validity of a claim about a congenital adrenal hyperplasia, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "validity-and-supersession-q02", "text": "Who or what asserted this about the validity of a claim about a congenital adrenal hyperplasia, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "validity-and-supersession-q03", "text": "What may an agent decide or do once the validity of a claim about a congenital adrenal hyperplasia is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] } ] }, "statistics": { "bundles": 5, "layers": 10, "findings": 12, "questions": 32 } } } }